Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Drugs & Aging
|
January 1, 1996
Drug treatment of Alzheimer's disease. Effects on caregiver burden and patient quality of life
L Hollister, N Gruber
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
January 1, 1991
Simulated home treatment of depression with nortriptyline
C Peabody, J Van Norman, L Hollister, et al.
Clinical Pharmacokinetics
|
May 1, 1985
Discrepancies between pharmacokinetic studies of amitriptyline
P Schulz, P Dick, T F Blaschke, et al.
Cancer Research
|
June 15, 1989
Differential effects of tranylcypromine and imidazole on mammary carcinogenesis in rats fed low and high fat diets
D L McCormick, A M Spicer, J L Hollister
Pharmacopsychiatry
|
February 1, 1990
Late clinical testing of cognition enhancers: demonstration of efficacy
G Schwartz, J C Bisserbe, D Bradford, et al.
Psychopharmacology
|
January 1, 1981
Clinical effects and plasma levels of delta 9-tetrahydrocannabinol (delta 9-THC) in heavy and light users of cannabis
J E Lindgren, A Ohlsson, S Agurell, et al.
International Clinical Psychopharmacology
|
January 1, 1987
Treatment-resistant schizophrenia: controlled study of moderate- and high-dose thiothixene
C C Huang, R P Gerhardstein, D Y Kim, et al.
Carcinogenesis
|
September 1, 1990
Enhancement of murine hepatocarcinogenesis by all-trans-retinoic acid and two synthetic retinamides
D L McCormick, J L Hollister, B J Bagg, et al.
Psychiatry Research
|
May 31, 1996
Brain glucose metabolism in chronic marijuana users at baseline and during marijuana intoxication
N D Volkow, H Gillespie, N Mullani, et al.
Psychiatry Research
|
May 1, 1991
Cerebellar metabolic activation by delta-9-tetrahydro-cannabinol in human brain: a study with positron emission tomography and 18F-2-fluoro-2-deoxyglucose
N D Volkow, H Gillespie, N Mullani, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Drugs & Aging
|
January 1, 1996
Drug treatment of Alzheimer's disease. Effects on caregiver burden and patient quality of life
L Hollister, N Gruber
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
January 1, 1991
Simulated home treatment of depression with nortriptyline
C Peabody, J Van Norman, L Hollister, et al.
Clinical Pharmacokinetics
|
May 1, 1985
Discrepancies between pharmacokinetic studies of amitriptyline
P Schulz, P Dick, T F Blaschke, et al.
Cancer Research
|
June 15, 1989
Differential effects of tranylcypromine and imidazole on mammary carcinogenesis in rats fed low and high fat diets
D L McCormick, A M Spicer, J L Hollister
Pharmacopsychiatry
|
February 1, 1990
Late clinical testing of cognition enhancers: demonstration of efficacy
G Schwartz, J C Bisserbe, D Bradford, et al.
Psychopharmacology
|
January 1, 1981
Clinical effects and plasma levels of delta 9-tetrahydrocannabinol (delta 9-THC) in heavy and light users of cannabis
J E Lindgren, A Ohlsson, S Agurell, et al.
International Clinical Psychopharmacology
|
January 1, 1987
Treatment-resistant schizophrenia: controlled study of moderate- and high-dose thiothixene
C C Huang, R P Gerhardstein, D Y Kim, et al.
Carcinogenesis
|
September 1, 1990
Enhancement of murine hepatocarcinogenesis by all-trans-retinoic acid and two synthetic retinamides
D L McCormick, J L Hollister, B J Bagg, et al.
Psychiatry Research
|
May 31, 1996
Brain glucose metabolism in chronic marijuana users at baseline and during marijuana intoxication
N D Volkow, H Gillespie, N Mullani, et al.
Psychiatry Research
|
May 1, 1991
Cerebellar metabolic activation by delta-9-tetrahydro-cannabinol in human brain: a study with positron emission tomography and 18F-2-fluoro-2-deoxyglucose
N D Volkow, H Gillespie, N Mullani, et al.
Page
of 2